Natural Products
| Catalog No. | Information |
| CFN95188 | Astin B Astin B has antitumor activity. |
| CFN95187 | Astin A Astin A has antitumor activity. |
| CFN95186 | Bergaptol-beta-glucopyranoside Reference standards. |
| CFN95185 | New compound 4 Reference standards. |
| CFN95184 | New compound 3 Reference standards. |
| CFN95183 | Pterodonoic acid Reference standards. |
| CFN95182 | Tessaric acid Tessaric acid has antifeedant and allelochemical effects. Tessaric acid derivatives induce G/M cell cycle arrest in human solid tumor cell lines. |
| CFN95181 | New compound 2 Reference standards. |
| CFN95180 | Isonardosinone Isonardosinone shows potential role in the treatment of neuroinflammation conditions, it inhibits NF-κB- and MAPK-mediated inflammatory pathways. |
| CFN95179 | Yuanhunine Reference standards. |
| CFN95178 | Citrusin B Citrusin B exhibits moderate in vitro inhibitory effect on tobacco mosaic virus replication with IC₅₀ values 0.26 mmol L⁻1. |
| CFN91131 | Hydroxy-alpha-sanshool Hydroxy-alpha-sanshool exerts antiobesity and hypolipidemic activities in HFD rats by reducing liver oxidative stress and thus could be considered as a potential candidate drug to cure or prevent obesity and hyperlipidemia. It also has analgesic properties, it activates TRPV1 and TRPA1 in sensory neurons. |
| CFN95177 | Pueroside A Reference standards. |
| CFN91128 | 5'''-O-Feruloyl complanatoside B Reference standards. |
| CFN95176 | Polygalasaponin XXXV Reference standards. |
| CFN95175 | Polygalin J Reference standards. |
| CFN95174 | Marginatoxin Marginatoxin may be a promising chemopreventive agent for treating hepatocellular carcinoma, it induces human hepatoma BEL-7402 cells apoptosis in vitro and in vivo via activation of Fas/FasL-mediated apoptotic pathway. |
| CFN95173 | Licoricesaponin H2 Reference standards. |
| CFN95172 | ent-16beta,17-dihydroxy-9(11)-kauren-19-oic acid Reference standards. |
| CFN95171 | 1,7-Diphenyl-5-hydroxy-4,6-hepten-3-one Reference standards. |
| CFN95170 | Momordicoside X Momordicoside X displays moderate insulin secretion activity. |
| CFN95169 | 24-Hydroxymomordicine III Reference standards. |
| CFN95168 | 3,7,23,24-tetrahydroxycucurbita-5,25-dien-19-al Reference standards. |
| CFN95167 | Momordicine II Momordicine II may have antidiabetic activity, it significantly stimulated insulin secretion. It also can deter oviposition by L. trifolii significantly. |
| CFN95166 | Lanceolarin Reference standards. |
| CFN95165 | Specioside B Reference standards. |
| CFN95164 | Momordicine V Momordicine V can deter significantly the oviposition by L. trifolii on host plant leaves treated at 26.16 microg/cm2 leaf surface. |
| CFN95163 | Apigenin 7-O-(6''-O-malonylglucoside) Reference standards. |
| CFN95162 | Atractylochromene Atractylochromene is an inhibitor of β-catenin dependent Wnt pathway, it may be a potential chemotherapeutic agent for the prevention and treatment of human colon cancer. |
| CFN95161 | (1,5E,11E)-tridecatriene-7,9-diyne-3,4-diacetate Reference standards. |
| CFN95160 | Silychristin B Reference standards. |
| CFN95159 | Genistein 7-O-beta-D-glucopyranoside-4'-O-[alpha-L-rhamnopyranosyl-(1->2)-beta-D-glucopyranoside] Reference standards. |
| CFN95158 | 4-Hydroxybenzoyl choline Reference standards. |
| CFN95157 | Formononetin-8-C-beta-D-apiofuranosyl-(1->6)-O-beta-D-glucopyranoside Reference standards. |
| CFN95156 | Pueroside C Reference standards. |
| CFN95151 | Quercetin 3-Caffeylrobinobioside Reference standards. |
| CFN95155 | Puerol B (+/-)-Puerol B shows inhibitory activity on AGEs formation in vitro. |
| CFN95154 | 3-O-[5'''-O-feruloyl-beta-D-apiofuranosyl(1'''->2'')-beta-D-glucopyranosyl] rhamnocitrin Reference standards. |
| CFN95153 | Patulitrin Patulitrin has antioxidant, anti-inflammatory, and larvicidal activities, oral and topical administration of patuletin and patulitrin inhibited acute inflammation in mice. |
| CFN95152 | New Compound 1 Reference standards. |
| CFN95150 | 3,7,25-Trihydroxycucurbita-5,23-dien-19-al Reference standards. |
| CFN95149 | Silybin A Silybin A has oxidative effects, it shows stronger effects on cell growth inhibition and apoptosis induction than silybin. |
| CFN95148 | Ampelopsin G Reference standards. |
| CFN95147 | Leachianol F Reference standards. |
| CFN95146 | Leachianol G Reference standards. |
| CFN91116 | 5,7,3',4'-Tetramethoxyflavone 5,7,3',4'-Tetramethoxyflavone (TMF) possesses various bioactivities, including antifungal, antimalarial, antimycobacterial, and anti-inflammatory activities; it also exhibits chondroprotective activity by targeting β-catenin signaling in vivo and in vitro. TMF protects chondrocytes from ER stress-induced apoptosis through regulation of the IRE1α pathway.TMF inhibits the expression of tyrosinase, tyrosine-related protein (TRP)-1, and TRP-2 mRNA, which could be the mechanism of its melanogenesis inhibitory activity. |
| CFN95145 | Rhamnocitrin 3-apiosyl-(1->2)-glucoside Reference standards. |
| CFN95144 | Complanatoside C Reference standards. |
| CFN95143 | Dehydrojuncusol Dehydrojuncusol, a new inhibitor of hepatitis C virus RNA replication, it inhibits infection of different HCV genotypes by targeting the NS5A protein and is active against resistant HCV variants frequently found in patients with treatment failure. |
| CFN95142 | Daidzein-4'-glucoside Reference standards. |
